MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
AbbVie DIO Ratio 2011-2026 | ABBV
Annual DIO Ratio AbbVie
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.6 | 89.4 | 68.6 | 70.3 | 67.3 | 60.8 | 89 | 75.9 | 83.2 | 90.4 | 139 | 92.7 | 91.6 | 88.3 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 139 | 60.8 | 85.6 |
Quarterly DIO Ratio AbbVie
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85.1 | 99.6 | 102 | 93.9 | 91.9 | 91.7 | 56.5 | 84.9 | 84.8 | - | 28.8 | 38.1 | 74.4 | - | 67.3 | 67.2 | 71.3 | - | 59.8 | 81.4 | 120 | - | 86.2 | 91 | 92.1 | - | 79.8 | 75.7 | 76 | - | 90.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 120 | 28.8 | 79.6 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 9.13 | -0.76 % | $ 591 M |  USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.91 | 2.42 % | $ 6.69 M |  China |
 |
Edesa Biotech
EDSA
|
184 | $ 15.52 | -2.39 % | $ 49.6 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.47 | 1.19 % | $ 3.72 B | USA |
 |
Fortress Biotech
FBIO
|
210 | $ 2.24 | 0.9 % | $ 62.5 M | USA |
 |
Galapagos NV
GLPG
|
0.915 | $ 28.07 | 0.75 % | $ 2.69 B |  Belgium |
 |
Grifols, S.A.
GRFS
|
0.000171 | $ 8.2 | 3.6 % | $ 6.83 B |  Spain |
 |
Harmony Biosciences Holdings
HRMY
|
11.6 | $ 31.01 | -0.13 % | $ 1.78 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
ImmuCell Corporation
ICCC
|
185 | $ 8.44 | - | $ 76.2 M | USA |
 |
Immuron Limited
IMRN
|
1.32 K | $ 0.83 | 3.44 % | $ 6.55 M |  Australia |
 |
Incyte Corporation
INCY
|
78.4 | $ 98.87 | -0.23 % | $ 19.3 B | USA |
 |
InMed Pharmaceuticals
INM
|
309 | $ 0.71 | 1.28 % | $ 1.74 M |  Canada |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Jaguar Health
JAGX
|
916 | $ 7.55 | -4.13 % | $ 17.6 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
203 | $ 26.67 | -0.02 % | $ 1.44 B | Britain |
 |
Kamada Ltd.
KMDA
|
166 | $ 8.15 | 0.49 % | $ 260 M |  Israel |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
235 | $ 223.98 | -0.39 % | $ 4.1 B | USA |
 |
Aquestive Therapeutics
AQST
|
120 | $ 4.08 | 0.74 % | $ 436 M | USA |